LMRI · Nasdaq · ·
$14.82-0.8%Nov 13 close
The latest quarter (ended September 30, 2026) is from Lumexa Imaging’s earnings press release of November 10, 2026. It will be replaced by the official quarterly report (10-Q) once Lumexa Imaging files it.
Just reported
From Lumexa Imaging's results release of November 10, 2026. These are the company's first figures; its 10-Q or 10-K replaces them when filed.
Actual
$272M
+3.0% q/q
Guided
—
No guide given
Actual
$0.07
+133% q/q
Guided
—
No guide given
EPS, adjusted: $0.26
Actual
$28.1M
+22% q/q
Guided
—
No guide given
Full year 2026
Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.
The themes Lumexa Imaging is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
Graded A or B and worth $2B or more: A first, then the largest.
Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
Built from Lumexa Imaging Holdings, Inc.’s own filings with the U.S. Securities and Exchange Commission (SEC). Figures are as reported, with per-share history restated onto today’s share basis. This describes a business — it is not investment advice and not a recommendation to buy or sell anything.
Company outlook: revenue of $1B to $1.1B for Fiscal year 2026
Not rated
The band under the price shows the grade on each date, built only from filings that were public by then.
There is no grade history to chart for Lumexa Imaging Holdings, Inc. yet. The quarterly grade is rebuilt from only the filings that were public at the time, and this company has not yet reported enough of them to score a single quarter.